OPERATING GRANTS COMPETITION

APPLICATION DEADLINES

Letter of intent: December 8, 2014

Full application: February 17, 2015

The operating grant is the principal means by which the Cancer Research Society fulfills its mission to support basic and fundamental research on all types of cancer in order to contribute to the advancement of science aimed at preventing, detecting and treating this disease.

Our Operating Grants Competition takes place every year and is open to researchers across Canada.

Instructions for Application
Eligibility Requirements
Grant Term and Amount
Financial Rules
Additional Specific Grant Opportunities 
Reporting
Evaluation Procedure
Accepting a Grant Offer

Application Toolkit

Letter of Intent:

Letter of Intent Form 2015
Instructions - Letter of Intent 2015

Complete Application:

Application Form 2015
Disclaimer and Indemnity Page 2015

Program Officer

Lucille Beaudet, PhD, MBA

grants@src-crs.ca
514-861-9227, ext. 234
Toll-free: 1 888 776 2262, ext. 234

Partnerships

See the list list of additional grant opportunities in specific areas of cancer research

 

OPERATING GRANTS CALENDAR

Letter of Intent

November 10, 2014

Letter of intent form available online

December 8, 2014

Deadline for submitting letter of intent

December 19, 2014

Results of the letters of intent are announced

Full  Application

December 19, 2014

Application form available online

February 17, 2015

Deadline for submitting full application

*Only those applicants whose letter of intent has been approved may submit a complete application

August 2015

Results are announced following approval by the Cancer Research Society’s Board of Directors

September 1, 2015

Payments to grantees begin

  Top of page

 


 


INSTRUCTIONS FOR APPLICATION

INSTRUCTIONS FOR COMPLETING THE INTERACTIVE PDF FORMS

** Please do not print and scan your completed pages.

The submission of a letter of intent or application requires completing the appropriate interactive PDF form, downloadable by clicking on the links below. 

To complete and save the form, you will need either Acrobat Pro, Standard  or Acrobat Reader version XI (you cannot save forms with previous versions of Acrobat Reader)

For those using Acrobat Standard or Pro (preferred software) 

  • You can save the completed letter of intent and application form at all times.
  • Software or subscriptions to Acrobat software can be purchased online.
  • Free 30-day trials are available.


For those using Acrobat Reader XI (not recommended for the complete application form)

  • You can save the completed Letter of Intent form at all times. If you are unable to save the forms, you do not have Acrobat Reader version XI installed on your computer.
  • Acrobat Reader XI does not allow inserting pages in the complete Application form and is thus not recommended for this form. If you do not have access to Acrobat Pro or Standard (free trials available on their official website), you should save the form with Acrobat Reader XI without any appendix and provide each appendix as a separate, well-identified, pdf file. 
  • Acrobat Reader XI can be downloaded for free from the official Acrobat website.

DO NOT DOWNLOAD ACROBAT READER FROM ANY OTHER WEBSITE.

Non-official websites proposing the download of Acrobat Reader XI might install malicious software on your computer. The Society is not responsible for any damage or inconvenience malicious software could cause to your system. 

Do not print and scan your application. 

DOCUMENTS TO DOWNLOAD
Letter of Intent: Form - Letter of Intent 2015
Instructions - Letter of Intent 2015
   
Complete Application: Application Form - 2015
  Disclaimer and Indemnity page - 2015

LETTER OF INTENT

Submitting a letter of intent is a preliminary and compulsory step in the application process that helps ensure the validity of the project and organize the evaluation committees. 

Failure to submit a letter of intent will result in the rejection of a complete application. 

Deadline for submission of the Letter of Intent:
December 8, 2014 at midnight (EST)

The filename of your letter of intent must be structured as follows:

“Last name_First name_ Letter of Intent_OG2015”.  For example, “Smith_John_Letter of Intent_OG2015”.

For applicants submitting more than one letter of intent, please differentiate between your forms by numbering them. For example: “Smith_John_Letter of Intent _OG2015_1

Please indicate the filename of your letter of intent in the subject of the e-mail you will send, i.e., “Last name_First name_ Letter of Intent_OG2015”.

For applicants submitting more than one letter of intent, please differentiate between your forms by numbering them and sending them in separate e-mails.

Please note that all applicants will be notified as to the status of their letter of intent by e-mail no later than December 19, 2014.

Only those applicants whose letter of intent has been approved may submit complete applications.

SUBMISSION OF THE LETTER OF INTENT

Deadline Submission of Letter of Intent: December 8, 2014 at midnight (EST).

Once completed, you must email your letter of intent form to: grants@src-crs.ca

Please indicate the filename of your Letter of Intent in the subject of the email you will send.

For applicants submitting more than one letter of intent, please differentiate between your forms by numbering them and send them in separate emails.

SUBMISSION OF THE COMPLETE APPLICATION

Deadline Submission of the complete applications: 
February 17, 2015.  Applications must be postage stamped no later than this date.

Once completed, you must mail (regular or courier) your application to the following address:

Cancer Research Society
C/O Research Department
625 President-Kennedy Avenue, Suite 402
Montreal, QC H3A 3S5

**APPLICATIONS SENT BY EMAIL ARE NOT ACCEPTED. WE WILL NOT ACCEPT SCANNED APPLICATIONS.

 Your application must contain the following:

* Two (2) electronic copies saved on two (2) CDs (1 copy per CD).

The filename of your application should end with the identification number (PIN) received in the Acceptance e-mail for your letter of intent as described below:

 Last name_First name_OG2015 Application_20XXX

For example:

Smith_John_OG2015 Application_20878

This filename should also appear on both CDs.

For applicants submitting more than one application, you must differentiate them by adding at the end of the filename their respective identification number (PIN) received in the LOI Acceptance e-mails.

Smith_John_OG 2015 Application _20878

Smith_John_OG 2015 Application _20884

You should not number your files in any other way!

 

* One (1) paper copy including all appendices and the following pages: 

1.The original “Disclaimer and Indemnity” pages (downloadable by clicking on the above links). After all signatures have been obtained, please include the original pages in the postal mailing of your application due February 17th, 2015. A copy should also be inserted in the appropriate order in your electronic copies or saved as a separate file.

 2. Copies of the certificates for research involving human subjects, animals or biohazards requiring containment. These certificates may follow the application’s approval for funding but must be received before the release of the first installment.


DISCLAIMER AND INDEMNITY PAGE

Please fill out and print the document entitled:
“Disclaimer and Indemnity Page 2015”.

This page must be signed by all applicants, co-applicants and their respective officials. After all signatures have been obtained, please include the original in the postal mailing of your application. Electronic signatures are also accepted. 

A scanned copy should also be included in your electronic copies, inserted in the PDF version of you application,  or saved as a separate file on your CDs.

AWARDS AND PUBLICATIONS UPDATES

Applicants may update their award notices and publication lists after submission of their full applications.

Publication updates may be provided via e-mail to grants@src-crs.ca up to April 30, 2015.

GENERAL INSTRUCTIONS

The degree of conciseness and clarity in the presentation can significantly influence the evaluation of the application.

All information required for the evaluation of the application must be included in the form, or attached to the form as indicated in the specific instructions in each section. If you do not have Acrobat Standard or Pro, use Acrobat Reader XI and save your form and appendices in well identified separate files. Do not send the file of the scanned application!  

The settings of the different document fields are pre-set (please do not modify them). 

When additional pages are allowed, the typeface must be in black ink. 

The only acceptable font is Times New Roman.

The character size measured in points (pt) must be no smaller than 12 pt

Condensed type is unacceptable.

The number of pages and/or documents must be limited to the detailed instructions in each section.

Please note that the disrespect of these rules could lead to an automatic rejection of your submitted application prior to its scientific evaluation.

 
  Top of page

 

ELIGIBILITY REQUIREMENTS

ELIGIBLE APPLICANTS

All applicants and co-applicants must hold an academic appointment in a Canadian university or accredited institution.

Collaborators may be from outside of Canada but no funds from the Cancer Research Society may be transferred outside of the country.

All applicants must be Canadian citizens or permanent residents.

Candidates in postdoctoral training are not eligible.

There must be only one main applicant for the purposes of this award. This person will also administer any grant awarded.

All other applicants are considered co-applicants.

ELIGIBLE PROJECTS

The Cancer Research Society Operating Grants award program is offered to research projects in basic or fundamental research exclusively. Applied, psychosocial or clinical research projects are not admissible to this program.

MULTIPLE APPLICATIONS

The number of applications a researcher may submit to the program as a main applicant is not limited.

A researcher may also participate in other projects as a co-applicant.

  Top of page

 

GRANT TERM

PERIOD OF FUNDING

Operating Grants are usually awarded for a period of 2 years.

All awarded grants take effect as of September 1st

RENEWAL OF GRANT

Researchers who currently have a grant with the Cancer Research Society may submit an application to renew their current project. 

A project that has already been the subject of an application for renewal or a project for which the financial support granted by the Cancer Research Society is already completed cannot be considered for a renewal application.

The letter of intent is also compulsory for operating grant renewals.

Conditional upon approval, a renewal may be granted for an additional two (2) years.

Please note that if the grant is not renewed, no terminal grant should be expected. Applicants should ensure that their internal arrangements allow for possible non-renewal of the grant.

Applicants whose grants have not been renewed can subsequently apply for a new operating grant in the next competition.

  Top of page

 

GRANT AMOUNT

GRANT AMOUNT

$60,000 per year

Researchers submitting an application for less than $60,000 and who qualify for funding will receive their grant for the amount requested.

MANAGEMENT

The annual funding period is from September 1 to August 31 of every year.

  • Payments of Operating Grant are made to the financial officer of the awardees.
  • Payments are made on a quarterly basis: September, December, March, June.

 

  Top of page

 

FINANCIAL RULES

ELIGIBLE EXPENDITURES

Cancer Research Society allows funding for:

  • salaries of students and post-doctoral fellows
  • salaries of research staff ( research assistant, research associate, technician)
  • research supplies
  • publication fees


Cancer Research Society funds cannot be used for:

  • remuneration of principal investigators, co-investigators and collaborators
  • all indirect expenditures related to layout organization or reorganization, facilities leasing and maintenance or the indirect costs covered by the host institution
  • equipment acquisition
  • travel expenses, sabbatical leave or maternity/parental leave
  • meetings, seminars or conferences: all expenses related to these activities including registration fees, travel, etc.
  • living expenses
  • clinical drug trials

Funds may not be transferred outside of Canada.

Any funds not spent for their original purpose by the end of the award period (2 or 3 years depending on carry forwards), must be returned to the Cancer Research Society.

CARRY FORWARDS

For a continuing grant, up to 25 percent (25%) of the annual award may be carried over to the next year.

For a terminating grant, up to 15 percent (15%) of the annual award may be carried over for up to one (1) additional year without a written request.

If the amount exceeds the percentages indicated above, a formal written request for a carryover (for a continuing grant) or an extension (for a terminating grant), addressed to the Cancer Research Society (by email at grants@src-crs.ca) is required. This request must include the following information:

  • amount of funds remaining
  • reason the funds were not spent for their intended purpose
  • how the remaining funds will be used
  • requested timeframe needed

 

  Top of page

 

ADDITIONAL GRANT OPPORTUNITIES 

Over the last few years, the Cancer Research Society is pleased to offer additional operating grants to the scientific community through our regular competition.

These grants on specific types of cancer are in addition to the regular operating grants applicable to the broad field of cancer. 

The funding of these specific grants is made possible thanks to significant collaborations that the Cancer Research Society has developed over the last years with valuable partners. If you apply for a specific grant award, you must check the designated box or boxes on the Letter of Intent and Application forms. You will be required to justify, on the Application form, how your project applies to the specific area(s) of research you selected.

 

ADDITIONAL GRANT OPPORTUNITIES
IN SPECIFIC AREAS OF CANCER RESEARCH FOR 2014

Breast Cancer: 
Partnership to be confirmed
Environment-Cancer: 
Four (4) operating grants supported through the Cancer Research Society’s Environment-Cancer FundTM in partnership with Read for the Cure are available.

Grants in environment-cancer are dedicated to finding scientific evidence relating the risk of developing cancer to the impact of environmental factors, such as our lifestyle (eating habits, physical activity, etc.) and our working, leisure and living environments.

Since 2006, the Environment-Cancer FundTM is funded in part by Read for the Cure, a non-profit volunteer organization, formed by passionate Canadian book lovers.

Neuroendocrine Tumours: 
Partnership to be confirmed

Childhood Cancer:
C17 is a non-profit organization led by experts in pediatric oncology/hematology to encourage and develop collaborative research that will ultimately improve health outcomes and quality of life for children in Canada who are fighting cancer. Applications are sought that fit within the shared scope of C17 and the Cancer Research Society—those that focus on discovery to translational research in children, with a clear potential for future application to novel therapeutic approaches, improved treatment efficacy or reduced immediate- to late-effects resulting from the biological consequences of cancer, anti-cancer treatment, or both. 
Multiple myeloma: 
Through a partnership with Myeloma Canada, the Cancer Research Society will be co-funding one (1) additional operating grant on multiple myeloma. The research project must be directly related to myeloma and aligned to the objective of improving patient outcomes within two to three years. As such, priority will be given to the submission deemed to have the greatest probability of positively impacting clinical practice within the defined time frame. The focus will be on proposals that contribute to the advancement of clinical practice through translational research. 

Ovarian Cancer: 
Through a partnership with Ovarian Cancer Canada, the Cancer Research Society will be co-funding two (2) operating grants on ovarian cancer.

Indolent non-Hodgkin’s lymphoma:  
Through a partnership with the Bergeron-Jetté Foundation, the Cancer Research Society will be co-funding one (1) operating grant on indolent non-Hodgkin’s lymphoma.
Pancreatic Cancer: 
Through partnerships with the Charlotte Légaré Memorial Fund and the Ganotec/Marc-André Pigeon Fund , the Cancer Research Society will be co-funding two (2) operating grants on pancreatic cancer. A third partnership on pancreatic cancer remains to be confirmed.

 
  Top of page

 

REPORTING

REPORT FORMS

Financial Report Form

Progress Report Form

FINANCIAL REPORTS

Deadline for Financial Report:
November 30, at the end of each funding year.

At the end of each funding year (i.e. August 31) and before November 30 (three months later), the host institution must return a brief financial statement to the Cancer Research Society attesting to the fact that the funds have been disbursed for their intended purpose.

FINANCIAL REPORTING INSTRUCTIONS FOR FINANCIAL OFFICERS:

Prior to filling out the form, please carefully read the appropriate financial rules and reporting obligations specific to the Cancer Research Society funding (Financial Rules).

Please use the appropriate Cancer Research Society form to submit your financial report, downloadable by clicking on the above link. (Link: Financial Report Form)

Once completed, print the form in order to obtain original signatures, then scan and send to the Cancer Research Society, by e-mail to grants@src-crs.ca.

Original (paper) reports are not required.

PROGRESS REPORTS Deadline for Financial Report: 
November 30, at the end of the project.

For all terminating projects, regardless of whether or not a renewal of the project has been accepted for funding, a final progress report is required from the principal investigator in order to follow the status of the research project.

In the case of certain partnerships, a progress report may be asked at the end of each funding year. Please follow the instructions included in the official grant offer provided to you upon acceptance.

Send all completed reports to the Cancer Research Society by e-mail to grants@src-crs.ca.

Original (paper) reports are not required.

PUBLICATIONS AND OFFICIAL COMMUNICATIONS

The financial support awarded by the Cancer Research Society must be acknowledged in all forthcoming publications and presentations, by properly using our name: Cancer Research Society or Société de recherche sur le cancer

For operating grants jointly funded by the Cancer Research Society and a partner, both the Cancer Research Society and the partner must be acknowledged in all forthcoming publications and presentations.
Please follow the instructions included in the official grant offer provided to you upon acceptance.

The Cancer Research Society requests to be informed in advance of any media relations activities (i.e. press releases, interviews, newspaper articles, etc.) regarding the work and or a discovery of a researcher funded by the Cancer Research Society so as to include our participation (quote, etc).

A copy of each publication must also be sent by e-mail in PDF format to
grants@src-crs.ca.

When the Cancer Research Society needs to be mentioned along with other granting agencies, it may become necessary to explain what portion of the research was specifically supported by the Cancer Research Society. 

  Top of page

 

EVALUATION

PANEL DESCRIPTION

All applications are reviewed by one of our peer-review committees made up of 9 to 15 Canadian and/or international scientists with expertise in the appropriate domains of cancer research. The applications are assessed based on the research area and topic and are categorized into one of the four following panels:

Panel A: Cell Signaling
Panel B: Pharmacogenetics/Cancer Immunology
Panel C: Tumour suppressor genes, oncogenes and DNA repair
Panel D: Tumour progression and metastasis

To consult the different topics covered in each panel, please click here

The Cancer Research Society will try to assign the application to the first panel choice selected by the researchers. However, we reserve the right of making the final decision regarding the assignment of the application to either one of the two selected panels.  

EVALUATION CRITERIA

Panel reviewers use the following criteria for the review of an application:

  • originality of the research plan
  • ability of the investigator to conduct the research in their respective milieu
  • significance of the project to cancer research
  • strengths and weaknesses of the proposal
  • budget relevance:
    • No monies are allowed for travel or equipment.
    • The budget must be appropriate to the proposed project.

 

SCORING

The expert panels conduct a critical and distinct analysis of each application, which is first reviewed and scored by two expert and impartial reviewers, to then be discussed and scored by the entire panel. 

The overall scientific score of the research project is determined after a thorough discussion of the application by the entire evaluation committee and may differ from the initial scores attributed by the two reviewers providing written evaluation reports.

Cancer Research Society funding is allocated to the projects with the highest scores and, where applicable, to the projects that fulfill the requirements for grants on specific cancer research topics as a result of partnerships with the Cancer Research Society.

To be considered for funding, a project must meet the Cancer Research Society’ assessment criterion of a minimum score of 7.5 out of 10.

Due to the high quality of proposals received each year and lack of available funds, not all projects having obtained this minimum scientific score are funded. 

All applicants, regardless of their score, will receive an official letter notifying them of the outcome of their application.

If an applicant refuses offered funding, the Cancer Research Society will offer the grant to the next meritorious project on the list.

Cancer Research Society decisions are final.

 

  Top of page

 

ACCEPTING A GRANT OFFER

OVERVIEW

In accepting a grant from the Cancer Research Society, the grantee and all co-applicants agree to observe and comply with the terms and conditions stipulated in the program description listed on this page, as well as on the signed Disclaimer and Indemnity page submitted with the complete application.

In addition, the grantee and all co-applicants agree to comply at all times with the general principles of honesty and scientific ethics, especially in relation to using the research funds received from the Cancer Research Society for their intended purpose, and the Policy regarding open access to published research outputs.

The award will be revoked if the grantee and co-applicants fail to comply with these rules.

AWARD ACCEPTANCE PROCEDURE 

Upon acceptance of an award, different actions need to be taken by the principal investigator in order for the award to take effect:

1. Formally accepting the award and its pertaining rules in writing (by email to grants@src-crs.ca) while stating that no overlap of the project exists, before the deadline indicated in the Grant Offer. 

Should the Cancer Research Society fail to receive this notice of acceptance, it will consider the principal investigator as having refused the grant.

2. Advising the official in charge of the financial management of research grants in his/her organization of the award and its pertaining conditions by forwarding them a copy of their Cancer Research Society Grant Offer.

3. Completing and sending his/her researcher’s profile, including a recent picture, for our website and donor relations. 

Fill out our online Profile Form.

RESEARCH ETHICS AND CERTIFICATION

Every project involving human or animal subjects requires the approval of the research ethics board of the principal investigator’s institution. Disbursement of the grant is contingent on provision of an ethics certificate and related documents to the Cancer Research Society.

Certificates may follow the application’s approval for funding but must be received before the payment of the first installment.    

The award will be revoked if the Grantee and co-applicants fail to comply with these rules.

OVERLAP WITH OTHER FUNDING

Each application submitted to the Society must be original. The Society will not award a grant overlapping fully or partially with a grant obtained from another funding agency for the support of a project. 

Should an applicant choose to accept a grant from another funding agency for a fully or partially overlapping project, it is incumbent upon him or her to inform the Cancer Research Society immediately of these circumstances.

Failure to comply with these rules will lead to the cancellation of an awarded grant. Where applicable, a grantee may be required to reimburse paid installments for a grant obtained which was not in compliance with the Society’s rules.

 

  Top of page

Please forward questions to grants@src-crs.ca.